相关实验视频
Updated: Jun 17, 2025

03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
2.0K
怀孕不良结果与膀过活的关联 抗胆固醇药物
Blayne Welk, J Andrew McClure1, Eric McArthur
1London Health Sciences Centre, London, Ontario, Canada.
Urogynecology (Philadelphia, Pa.)
|August 8, 2024
概括
在怀孕期间使用过度活性膀 (OAB) 抗胆固醇药物会增加怀孕并发症的风险,如早产或低出生体重. 然而,这种药物的使用与新生儿的先天性形无关.
科学领域:
- 药物监督 药物监督 药物监督
- 生殖健康 生殖健康
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 怀孕期间使用过度活性膀 (OAB) 抗胆固醇药物的安全性在很大程度上是未知的.
- 这些药物在人类怀孕中的产性数据有限.
研究的目的:
- 调查OAB抗胆固醇在怀孕期间使用与不良妊娠结果之间的关联.
- 为了确定OAB抗胆固醇在子宫中的暴露是否与先天性形有关.
主要方法:
- 使用加拿大医疗保健数据 (2004-2022) 的回顾性队列研究.
- 确定了18-45岁的妇女,她们在怀孕期间分娩并填写了OAB抗胆固醇处方.
- 使用波桑回归与治疗权重的逆概率来评估妊娠并发症和发育不良的风险.
主要成果:
- 在138,271个分娩中,479个 (0.3%) 涉及OAB抗胆固醇暴露,主要是氧丁宁.
- 显著增加怀孕并发症的风险 (早产,低出生体重) 观察到 (RR 1.65).
- 在OAB抗胆固醇使用和先天性形之间没有发现显著的关联 (RR 1.24).
结论:
- 孕妇使用OAB抗胆固醇药与妊娠并发症风险增加有关.
- 在使用OAB抗胆固醇药时,先天性形风险似乎没有增加.
- 调查结果有助于就孕期OAB药物风险向生育年龄的妇女提供咨询.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
733
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
733
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
650
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
650
Cholinergic Antagonists: Pharmacological Actions
1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
566
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
566
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
255
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
255
Cholinergic Antagonists: Pharmacokinetics
425
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
425

